Andrzej P.
- Country
- Poland
- Department
- N/A
Research Overview
- A Multicenter, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Budiodarone in Subjects with Non-permanent Atrial Fibrillation
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Evaluation of Balcinrenone and Dapagliflozin on Cardiovascular Outcomes in Heart Failure Patients with Renal Impairment: A Phase III Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 172 of 729 partner sites.
Specializations
Paediatric haematology and oncology
Clinical trial activity includes acute lymphoblastic leukemia, acute myeloid leukemia, lymphoblastic lymphoma, myeloid leukemia in children with Down syndrome, and hepatoblastoma and other primary malignant liver tumors.
- Children with high-risk leukemia
- Infant ALL
- Relapsed or refractory AML
- Pediatric liver cancer
The therapeutic focus extends across risk-adapted treatment strategies for childhood blood cancers and solid tumours, with interest in improving disease control and reducing treatment-related toxicity.
Nephrology and autoimmune disease
Research involvement covers active proliferative lupus nephritis, systemic lupus erythematosus, chronic kidney disease, idiopathic steroid-sensitive nephrotic syndrome, and urinary tract infections including acute pyelonephritis and complicated urinary tract infection.
- Lupus nephritis
- Nephrotic syndrome
- Chronic kidney disease
- Complicated urinary infection
Therapeutic interests also include immune-mediated renal injury and kidney-related infectious complications, reflecting a broad engagement with renal and inflammatory disorders.
Endocrinology, growth, and metabolic medicine
Clinical research spans growth hormone deficiency, idiopathic short stature, small for gestational age, Turner syndrome, Noonan syndrome, classic congenital adrenal hyperplasia, type 1 diabetes, obesity, and weight management in adolescents.
- Pediatric growth disorders
- Congenital adrenal disorders
- Type 1 diabetes
- Obesity treatment
There is also involvement in cardiometabolic care linked to excess body weight and glucose regulation, with attention to endocrine conditions across childhood, adolescence, and adulthood.
Neurology and cardiovascular medicine
Trial activity includes relapsing multiple sclerosis, acute ischemic stroke, acute myocardial infarction, worsening heart failure, acute heart failure, non-permanent atrial fibrillation, and persistent pulmonary hypertension of the newborn.
- Demyelinating disease
- Stroke care
- Heart failure
- Atrial fibrillation
The therapeutic landscape also includes acute vascular protection, rhythm-related disorders, and neonatal cardiopulmonary disease, with emphasis on cardiovascular and neurological outcomes.
Gastroenterology, respiratory, and infectious disease
Additional research interests involve ulcerative colitis, breathing disorders as a cause of neonatal respiratory failure, and bacterial infections in paediatric populations, alongside broader antimicrobial and inflammatory care.
- Inflammatory bowel disease
- Neonatal respiratory failure
- Bacterial infection management
These areas reflect participation in therapeutic domains that address mucosal inflammation, neonatal respiratory compromise, and paediatric infectious disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.